| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
JP Morgan analyst Rachel Vatnsdal maintains Henry Schein (NASDAQ:HSIC) with a Overweight and lowers the price target from $8...
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $75 to $72.
Baird analyst Jeff Johnson maintains Henry Schein (NASDAQ:HSIC) with a Outperform and lowers the price target from $92 to $82.
Evercore ISI Group analyst Ross Muken maintains Henry Schein (NASDAQ:HSIC) with a In-Line and lowers the price target from $...
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and lowers the price targ...
Henry Schein Q2 adjusted EPS fell 6.1% to $1.23, beating the $1.22 consensus. Sales grew 1% to $3.10 billion, missing the $3.27...
Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.23 per share which beat the analyst consensus estimate of $1.22 by...
